Objective: This paper describes the mortality rates and trends from childhood cancer at the population level over a 37-year period in Japan and other developed countries.
introduction
It is estimated that 3000 Japanese children aged from birth to 18 years will develop cancer. Although childhood cancer is rare compared with adult cancer, it is the fourth most common cause of death among children aged 0-14 years in Japan, according to the report given by the Ministry of Health, Labor and Welfare of Japan in 2005. A population-based study in Osaka prefecture in Japan indicated that death due to childhood cancer declined from 1972 to 1995, while the incidence increased in the same period [1] . In the United States, an estimated 10 400 new cases and 1545 deaths are expected to occur among children aged 0-14 years in 2007 [2] . During recent three decades, the incidence of childhood cancer increased 0.6% annually. In contrast, mortality from childhood cancer declined by 1.3% per year during 1990-2004 [3] . A population-based study among European children since the 1970s showed that the overall incidence of childhood cancer has increased by 1.0% per year, while mortality has declined by 3.6% per year in the past three decades [4, 5] .
The decrease in mortality from childhood cancer has been suggested to be due to the effects of improvements in diagnosis and therapy. For all childhood cancers combined, 5-year relative survival has improved markedly over the past three decades, from <50% before the 1970s to 80% today [2] .
There is no national childhood cancer registry system in Japan, and recent childhood cancer mortality has not been well characterized in terms of temporal and geographic trends. This paper describes the occurrence of death from childhood cancer at the population level over a 37-year period in Japan using official death certification data, which record 100% of deaths in Japan. The aim of this study was to ascertain the general mortality trend for each sex and to study the moment at which a shift in the trend occurred.
materials and methods
The number of death by cause, stratified for sex and by 5-year age group for cancer for the period 1970-2006, was derived from vital statistics compiled by the Ministry of Health, Labor and Welfare of Japan. Population figures were obtained from census data and intercensus estimates, by calendar year, age and gender. Population censuses of Japan are conducted every 5 years by the Statistics Bureau, Ministry of Internal Affair and Communications. For comparison, we also calculated the cancer mortality rate in other developed countries, including Canada (1970 Canada ( -2004 , the United States , Italy (1970 Italy ( -2003 , UK (1970 UK ( -2005 and New Zealand ; ICD-10: C70-C72), malignant kidney tumors (ICD-8: 189; ICD-9: 189; ICD-10: C64-C68) and malignant bone tumors (ICD-9: 170; ICD-10: C40-C41). In order to avoid possible bias due to changed ICD, the analysis of CNS tumors, malignant bone tumors and lymphomas (United States only) was restricted to data from 1980 onwards.
Age-standardized mortality rates were calculated by the direct method using age-specific mortality rates for 5-year age intervals and weights based on the age distribution of the standard world population. All rates are expressed per 100 000 children-years. 
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The joinpoint regression model was used to describe changes in trends [6] . We allowed for up to four joinpoints for each model. The computation of mortality rates and their standard errors was implemented in SAS 9.0. Joinpoint analyses were carried out using Joinpoint software 3.3.1 from the Surveillance Research Program of the US National Cancer Institute. Time trends were assessed for all childhood cancer combined and for six major categories, including leukemia, lymphoma, malignant brain tumor, malignant kidney tumor and malignant bone tumor.
The standardized mortality ratio (SMR) by sex was calculated for 47 prefectures in Japan by taking the ratio of the observed to expected deaths. The z-value was computed for each SMR, on the basis of the assumption that observed deaths follow a Poisson distribution. The maps were developed using adjusted SMR by gender. results mortality Tables 1 and 2 give age-adjusted mortality rates in Japan and five other developed countries for all malignant tumors and for 4 .53% per year (P < 0.05) throughout the whole period. The average annual change in recent 10 years was 24.8% (P < 0.05%) for boys and 24.5% (P < 0.05%) for girls. Similar decline trends were also observed in Canada, the United States, Italy, UK (girls) and New Zealand.
In contrast with the dramatic decline in mortality for childhood leukemia, mortality rates from childhood CNS tumor in Japan remained stable at a low level for both genders during 1980-2006. The average annual change in recent 10 years was 0.5% (P > 0.05) for boys and 0.0% (P > 0.05) for girls. On the contrary, Canada, the United States, UK and New Zealand (girls) showed significant declining trends in the whole period.
With reference to the pattern of mortality for lymphomas, death rates for boys were stable during 1970-1985 and declined significant thereafter by 8.56% per year. The trend for girls leveled off during 1970-1991 and showed a declining trend of 11.85% per year during 1991-2006; however, except for New Zealand females, the death rates in other countries for both genders significantly declined throughout the whole period. 
Regression analysis also revealed that the death rate for malignant kidney tumors declined by 4.12% per year for boys and 3.98% per year for girls during 1970-2006. Similar trends were observed for malignant bone tumor. Mortality decreased by 2.03% per year for boys and 1.79% per year for girls throughout the whole period.
Mortality rates varied from prefecture to prefecture in Japan. A map of SMR by gender is shown in Figure 3 . The SMR was significantly highest among children in Kochi prefecture for boys and Tokushima and Kagoshima prefectures for girls.
discussion
In this study, we quantified the childhood cancer burden in Japan, focusing on mortality, and compared these figures with other developed countries. The results indicated that mortality from childhood cancer in Japan is substantial, while the number of deaths is small. There were 33 059 cases of childhood cancer death over the period 1970-2006 in Japan. Approximately 400 deaths each year were attributed to cancer in children aged 0-14 years. Mortality from all cancers combined in Japan is comparable to that in the European, North American and Oceanic countries included in this study for contrast.
The joinpoint regression method was used in our research to evaluate the trend in childhood cancer deaths. This method has allowed a detailed and accurate description of the pattern of childhood cancer mortality since it identifies the calendar years in which statistically significant changes in trends occurred. This offers a clearer picture of actual trends in mortality over long periods of time rather than using only one trend statistics. We also reported the average annual percentage change in this study. The AAPC can be used to characterize a short segment based on a joinpoint model fit over a much longer series. This is especially advantageous for situations when the data are sparse (e.g. a rare cancer or data from a small geographic area) [7] . Our results showed a declining cancer mortality rate for boys in the whole period and a stable trend for girls in recent 5 years. It is unlikely that the observed time trends in the mortality rate are due to variations in the completeness and accuracy of the population data because the analyzed data were provided by official sources and based on the population census. The significant time trend observed for most tumor types is congruent with improvements in diagnosis, therapy and supportive care.
The dramatic decrease in mortality observed for childhood leukemia, which accounts for 50% of all childhood cancer original article Annals of Oncology deaths, is consistent with improvements in survival, particularly for patients with acute lymphoblastic leukemia. This increase in survival is due to more effective antileukemic therapy, such as multidrug chemotherapy protocols, with a reduction in the number of relapses and resistant disease, but also due to improvements in supportive care, such as antibiotics, antifungal treatment, blood banking, transplant procedures and pediatric intensive care. In fact, the 5-year survival rate of acute lymphoblastic leukemia increased from 20% to 30% in the 1960s to 60% to 75% in the 1980s in developed countries. Current survival rates are 80% for acute lymphoblastic leukemia (ALL) [8] and 50%-70% for acute myelogenous leukemia. In Japan, a population-based study in Osaka prefecture indicated that the 5-year survival rate of childhood leukemia increased from 32.4% in 1975-1984 to 60.4 in 1985-1994 [1] . National incidence trends could not be Annals of Oncology original article obtained in the current study. Research in Great Britain [9, 10] , Italy [11] and Sweden [12] showed increased trends in childhood leukemia. A report from Britain indicated that small peaks in the incidence of ALL in 1976 and 1990 coincided with the years immediately following influenza epidemics [13] . Other explanations of the increased trend were characteristics of the environment, such as population mixing, although the etiology of cancer remains complicated and largely unknown.
The stable trend in mortality for childhood CNS tumor implied a modest increase trend in the incidence rate in Japan because of the survival improvement reported in childhood CNS tumors in developed countries in recent decades, while progress in therapy for brain tumors has not been as great as for leukemia. For CNS tumors, computed tomography, which was introduced in the 1970s, and magnetic resonance imaging, which has been used widely since the 1980s, has become original article Annals of Oncology a standard tool for CNS tumor diagnosis and evaluation [14] . Furthermore, improvements in neurosurgical techniques have occurred during the past two decades, including stereotactic surgery, Cavitron Ultrasonic Surgical Aspirator and so on. Childhood cancer survival research from Osaka prefecture in Japan reported a slight increase in 5-year survival [1] . Incidence trends were not evaluated in this study. Data from the population-based cancer registry of Hokkaido prefecture in Japan indicated that the incidence of childhood brain tumors has been increasing, though the cause is unknown [15] . Other studies conducted in developed countries reported a significant increase in childhood CNS tumor incidence [10, 12, [16] [17] [18] [19] [20] [21] . This has been explained by changes in detection and/or reports of childhood CNS tumors [22] . Because magnetic resonance imaging became ubiquitous at tertiary pediatric centers in the mid-1980s, it is likely to have increased the rate of detection; however, in the current study, the mortality rate of childhood CNS tumors in Japan was low and constant since the 1980s, and no significant increase in the number of deaths occurred in the middle of the 1980s to support the suggestion that the incidence increase was due to improved diagnostic techniques, if this increase really exists in Japan, and it seems unlikely to explain the long-term continued leveling off of mortality. The etiology of childhood CNS tumors remains largely unknown. Environmental factors are suggested to have a relationship with brain tumors. Further investigation in this field is needed to identify the incidence trends and reasonable explanations for these trends in Japan.
A previous childhood cancer mortality study in Japan presented data up to 1998. Furthermore, trend analysis was according to the correlation coefficient between the mortality rate and death year. Our analysis provides an updated mortality rate and reliable time trend analysis. In general, the mortality trends observed in other developed countries were compatible with Japan, although some differences were apparent. For example, a decrease in mortality during 0-14 years was observed in leukemia in the United States, Canada, Italy, New Zealand and Japan; however, the mortality rate from CNS tumors has decreased in the United States, Canada, UK and Italy in recent two decades. No evidence of decline appeared during 1980-2006 in Japan. For lymphoma, the decline occurred relatively late in Japan, compared with a significant decline without a leveling off period in the United States, Canada, Italy and UK. There is no simple explanation for these trend disparities. It is possible that the distribution of the histology pattern is markedly different among different countries, even in the same diagnostic group. The possible causes for these disparities in the childhood cancer death rate (e.g. late diagnosis, poor treatment quality, lack of health insurance and difficulty in accessing health care) need to be studied further.
A high mortality rate was observed in Kochi prefecture in boys and Tokushima and Kagoshima prefectures in girls. As mentioned above, the geographic disparity might be due to differences in cancer incidence and survival in different regions. Studies of the relationship between social class and childhood cancer have not been consistent. Research from Brazil suggested that higher decreases in the mortality rate were observed in more developed regions, possibly reflecting better health care [23] . We did not perform a similar ecologic study here, because of the small number of death, and we could not even calculate mortality by subtype by prefecture. Further detailed individual-level study is needed to identify a more reasonable explanation for the mortality disparities in childhood cancer.
A few points should be borne in mind when interpreting these findings. Some stable trends in the present study, such as mortality in lymphoma, and malignant bone tumors in New Zealand are more difficult to explain because of the small absolute number and substantial random variation. Other limitations included the wide time span and changes in diagnostic capabilities during the study period, and we were not able to collect any information on social status, employment of individuals and other genetic, environmental factors that would have allowed us to analysis etiological hypotheses.
Despite these limitations, when considering the absence of a national cancer registry system in Japan, estimates of incidence may have their own limitations (for example, they may be significantly influenced by errors in diagnosis and classification); evaluation of death may be an alternate effective method to identify more population-based point estimates of Annals of Oncology original article mortality from childhood cancer under these circumstances. Furthermore, the results presented here are based on 100% national coverage and provide an important baseline for monitoring the further progress against childhood cancer in Japan. Analysis of trends in national mortality rates over several decades may provide additional insight into the burden and impact of childhood cancer and suggest more targeted avenues for interventions that further delineate and ultimately reduce mortality from childhood cancer.
conclusions
The present study provides updated figures and trends in childhood cancer mortality in Japan and other developed countries. This will help to estimate care needs and to plan interventions and the quantity of appropriate childhood cancer treatment. Comprehensive efforts designed to identify risk factors for childhood cancer, promote early detection and reduce morbidity and mortality are warranted. 
